HAUSMAN MARVIN S MD

10% Owner, Director, Chairman, CSTO, Chairman,Chief Sci/Tech Offc, CEO, President, Acting CFO, President, CEO, Acting CFO, President, CEO, PRESIDENT, CEO, CEO, President & CEO, Interim CFO, Chairman & Interim CFO, Chairman & CEO, Chairman and CEO, Chief Executive Officer, Chair · SEC CIK 1067956
Advertisement

Buy track record

How this insider's open-market purchases have performed
0%
of buys now in profit
0 up · 3 down
Avg return since buy−99.1%
Median return−99.1%
Best trade−99.1%
Worst trade−99.1%
Buys scored3
Average return by holding period — separates good entry timing from riding one long winner
After 1 month +0.0% 0% won · 3 trades
After 3 months +0.0% 0% won · 3 trades
After 6 months +0.0% 0% won · 3 trades
After 12 months +0.0% 0% won · 3 trades
DateCompany90d trendBuy priceValueΔOwn1M3M6M12MTo date
Sep 25, 2014 ERGO $0 $648.9K +108% +0.0% +0.0% +0.0% +0.0% −99.1%
Dec 17, 2013 ERGO $0 $23.8K +2.6% +0.0% +0.0% +0.0% +0.0% −99.1%
Jul 12, 2013 ERGO $0 $50K +5.7% +0.0% +0.0% +0.0% +0.0% −99.1%
How this is calculated. We score only open-market purchases (SEC code P) — the buys that carry real signal. Each trade's return is measured from the adjusted closing price on the purchase date to the latest close, accounting for stock splits and dividends. The 1M/3M/6M/12M columns show the same trade's return after each fixed holding period; a dash means that horizon hasn't elapsed yet or isn't priceable. Sales are excluded because insiders sell for many routine reasons. With only 3 scored trades, treat this as a small sample, not a verdict.
Advertisement
Open-market buys
$722.6K
3 trades
Open-market sells
$806K
18 trades
Net flow
−$83.3K
Net selling
Total filings
35
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
Advertisement
ERGO
Buy HAUSMAN MARVIN S MD · Director, President, CEO, Acting CFO, 10% Owner · Open-market purchase · filed Nov 12, 2014 ΔOwn +108%

Hausman Marvin S Md, ERGO's CEO, spent $648.9K of their own money on 2.16M shares at $0, growing their stake 108%.

+$648.9K
2.16M sh @ $0
ERGO
Buy HAUSMAN MARVIN S MD · Director, President, CEO, Acting CFO, 10% Owner · Open-market purchase · filed Dec 19, 2013 ΔOwn +2.6%

Hausman Marvin S Md, ERGO's CEO, spent $23.8K of their own money on 62,505 shares at $0, growing their stake 3%.

+$23.8K
62,505 sh @ $0
ERGO
Buy HAUSMAN MARVIN S MD · Director, President, CEO, Acting CFO, 10% Owner · Open-market purchase · filed Jul 22, 2013 ΔOwn +5.7%

Hausman Marvin S Md, ERGO's CEO, spent $50K of their own money on 131,579 shares at $0, growing their stake 6%.

+$50K
131,579 sh @ $0
AXYX
Sell HAUSMAN MARVIN S MD · Director, Chairman & CEO · Open-market sale · filed Jan 13, 2005 ΔOwn −0.1%

Hausman Marvin S Md sold $15K of AXYX.

−$15K
2,500 sh @ $6
AXYX
Option exercise HAUSMAN MARVIN S MD · Director, Chairman and CEO · Option exercise · filed Dec 30, 2004 ΔOwn +2.1%
+$59K
50,000 sh @ $1
PARS
Sell HAUSMAN MARVIN S MD · Director, Chairman and CEO · Open-market sale · filed Dec 13, 2004 ΔOwn −0.2%

Hausman Marvin S Md sold $34.3K of PARS.

−$34.3K
5,000 sh @ $7
PARS
Sell HAUSMAN MARVIN S MD · Director, Chairman and CEO · Open-market sale · filed Dec 13, 2004 ΔOwn −0.2%

Hausman Marvin S Md sold $34.4K of PARS.

−$34.4K
5,000 sh @ $7
PARS
Sell HAUSMAN MARVIN S MD · Director, Chairman and CEO · Open-market sale · filed Dec 13, 2004 ΔOwn −0.2%

Hausman Marvin S Md sold $34.5K of PARS.

−$34.5K
5,000 sh @ $7
PARS
Sell HAUSMAN MARVIN S MD · Director, Chairman and CEO · Open-market sale · filed Dec 13, 2004 ΔOwn −0.2%

Hausman Marvin S Md sold $34.5K of PARS.

−$34.5K
5,000 sh @ $7
AXYX
Sell HAUSMAN MARVIN S MD · Director, Chairman & CEO · Open-market sale · filed Nov 10, 2004 ΔOwn −0.4%

Hausman Marvin S Md sold $64.5K of AXYX.

−$64.5K
10,000 sh @ $6
AXYX
Sell HAUSMAN MARVIN S MD · Director, Chairman & CEO · Open-market sale · filed Nov 10, 2004 ΔOwn −0.2%

Hausman Marvin S Md sold $32.3K of AXYX.

−$32.3K
5,000 sh @ $6
AXYX
Sell HAUSMAN MARVIN S MD · Director, Chairman & CEO · Open-market sale · filed Nov 10, 2004 ΔOwn −0.2%

Hausman Marvin S Md sold $32.4K of AXYX.

−$32.4K
5,000 sh @ $6
AXYX
Option exercise HAUSMAN MARVIN S MD · Director, Chairman & CEO · Option exercise · filed Nov 9, 2004 ΔOwn +2.1%
+$59K
50,000 sh @ $1
AXYX
Sell HAUSMAN MARVIN S MD · Director, Chairman and CEO · Open-market sale · filed Oct 19, 2004 ΔOwn −0.4%

Hausman Marvin S Md sold $60K of AXYX.

−$60K
10,000 sh @ $6
AXYX
Sell HAUSMAN MARVIN S MD · Director, Chairman and CEO · Open-market sale · filed Oct 19, 2004 ΔOwn −0.4%

Hausman Marvin S Md sold $60.1K of AXYX.

−$60.1K
10,000 sh @ $6
AXYX
Sell HAUSMAN MARVIN S MD · Director, Chairman and CEO · Open-market sale · filed Oct 19, 2004 ΔOwn −0.2%

Hausman Marvin S Md sold $30.2K of AXYX.

−$30.2K
5,000 sh @ $6
AXYX
Sell HAUSMAN MARVIN S MD · Director, Chairman and CEO · Open-market sale · filed Oct 19, 2004 ΔOwn −0.3%

Hausman Marvin S Md sold $45.8K of AXYX.

−$45.8K
7,500 sh @ $6
AXYX
Sell HAUSMAN MARVIN S MD · Director, Chairman and CEO · Open-market sale · filed Oct 19, 2004 ΔOwn −0.4%

Hausman Marvin S Md sold $61.5K of AXYX.

−$61.5K
10,000 sh @ $6

Frequently asked questions

How is HAUSMAN MARVIN S MD's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from HAUSMAN MARVIN S MD's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.